CURRICULUM VITAE Robert Strohal, MD - EWMA

More documents

Recommendations

Info

3/2010 • Die Behandlung local infizierter Wunden: Von der Evidence zum Therapiealgorithmus (Treatment of locally infected wounds: from evidence to a therapeutic algorithm), Lohmann & Rauscher Satellite Symposium at the Annual Conference of the German Society for the Treatment of Wounds, 14.6.2008, Koblenz, Germany • Die Wissenschaft hinter dem Hautschutz – wo wir stehen, wohin wir gehen (The science behind skin protection – where do we stay, where do we go), Round Table Discussion at the 9 th International Skin Protection Day, 18.6.2008, Krefeld, Germany • Psoriasis: Long-term disease – long-term solution, Wyeth Germany Internal Tertiary Meeting, 4.9.2008, Berlin, Germany • Psoriasis up date: Comorbidities and Biologics, Wyeth Optimus Dermatology/Rheumatology Meeting, 5.9.2008, Helsinki, Finland • Wie behandle ich Herpes zoster (How to treat herpes zoster), Menarini Pain Symposium, 27.9.2008, Pichl, Austria • Treatment of Psoriasis – up date, Wyeth Czech Dermatology Expert Meeting, 30.9.2008, Prag, Czech Republic • Lokal infizierte Wunden - : Von der Evidence zum Therapiealgorithmus (Locally infected wounds - from evidence to a therapeutic algorithm), 40 th Annual Conference of the Austrian Society of Vascular Surgeons. 10.10.2008, Vienna, Austria • Etanercept: efficacy, dosing regimen and safety profile in psoriasis, Wyeth Lunch Symposium at the Annual Meeting of the Rumanian Society of Dermatology, 17.10.2008, Sibiu, Romania • Lokal infizierte Wunden: Von der Evidence zum Therapiealgorithmus (Locally infected wounds - from evidence to a therapeutic algorithm), 7 th Vorarlberg Congress Nursing of Geriatric Patients, 29.10.2008, Nenzing, Austria • Broadening the clinical utility of Etanercept in psoriatic disease and etanercept: clinical trials and case studies, Lecture and Workshop at the 4 th Wyeth Psoriasis Summit of Middle East and North Africa, 4.-5.11.2008, Cairo, Egypt • Pädiatrische/juvenile Psoriasis (Pediatric/juvenile psoriasis), Wyeth Lunch Symposium at the Annual Meeting of the Austrian Society of Dermatology and Venerology, 29.11.2008, Vienna, Austria • Etanercept – Dosis, Regime und Sicherheit (Etanercept – dosage, regimen and safety), Meeting of the Bavarian Medical Assotiation of Dermatologists, 14.1.2009, Munich, Germany. • Psoriasis-co-morbidities, psoriasis-management of the disease and biologics-safety, 1 st Wyeth MENA Etanercept Speakers Bureau, 18.-19.1.2009, Dubai, United Arab Emirates • Up date on psoriasis treatment, Hungarian Etanercept Expert Meeting, 5.2.2009, Budapest, Hungary • Raising the bar in psoriasis treatment, 1 st Bahrain Society of Dermatology Psoriasis Symposium, 27.2.2009, Bahrain City, Bahrain • Genieße die Sonne, aber richtig (Enjoy the sun, but do it the right way), Annual Meeting of the Nursing Association Tosters, 20.3.2009. Feldkirch, Austria 24
3/2010 • The Presta trial, the Crystal study and pediatric psoriasis, 1 st Wyeth South American Etanercept Speakers Bureau, 26.3.2009, Amsterdam, Netherlands • Clinical decision making: management algorithms, what to do and when? and biologics – patient eligibility and treatment choice, Work shop and Meet-the Expert- Session at the Wyeth European Summit Progress and Promise, 27.3.2009, Amsterdam, Netherlands. • Humira und die Psoriasisarthritis – Studienergebnisse (Humira and psoriatic arthritis – results from the studies), Austrian Abbott Expert Board Meeting, 18.4.2009, Vienna, Austria • Practical aspects in the treatment of psoriasis, Wyeth Satellite Symposium at the 6 th EADV Spring Symposium, 24.4.2009, Bucharest, Rumania • Continuous versus intermittent therapy of psoriasis: what does your patient need? Wyeth Satellite Symposium at the 45 th Meeting of the German Dermatology Society, 4.4.2009, Dresden, Germany • Polihexanid – ein neuer vielversprechender Wirkstoff für die lokale anti-mikrobielle Therapie (Polihexanid – a new, promising compound for the local anti-microbial therapy), Lohmann & Rauscher Satellite Symposium at the Annual Meeting of the German Initiative Chronic Wounds, 6.5.2009, Bremen, Germany • The efficacy and safety of biologics in psoriasis, new data on Etanercept and clinical studies, Lecture and Workshop at the 5 th Wyeth Psoriasis Summit of Middle East and North Africa, 7.-8.5.2009, Beiruth, Lebanon • Sonne – Haut – Sport (Sun – Skin – Sports), Meeting of the Austrian Society Military Medicine, Section Vorarlberg, 11.5.2009, Bregenz, Austria • Polihexanid – ein neuer vielversprechender Wirkstoff für die lokale anti-mikrobielle Therapie (Polihexanid – a new, promising compound for the local anti-microbial therapy), Austrian Lohmann & Rauscher Educational Symposia and Workshops, 3.5. Vienna, 28.5. Zell am See, 4.6.2009 Graz, 9.6.2009 Salzburg, Austria • Outdoor exposure and other occupational exposures as risk factors for NMSC, Symposium SY10 at the 7 th World Congress on Melanoma and 5 th Congress of the European Association of Dermato-Oncology, lecture and chair, 13.5.2009, Vienna, Austria. • Polihexanid – a promising compound for the treatment of locally infected wounds, Lohmann and Rauscher Satellite Symposium at the 19 th Conference of the European Wound Management Association, 21.5.2009, Helsinki, Finnland • Heuschnupfen und Asthma (Hey fever and Asthma), MINIMED Teaching Series, 27.5.2009, Wolfurt, Austria • Polihexanid – a promising compound for the treatment of locally infected wounds. Lohmann and Rauscher Symposium for the Eastern European Countries, 28.5.2009, Zell am See, Austria • Psoriasis disease burden and co-morbidities, case series, and Etanercept up date, North German Wyeth Cooperative Dermatology Rheumatology Symposium, lectures and chair, 12.-13.6.2009, Dierhagen, Germany • Guidelines for the treatment of locally infected wounds, 11 th Annual Meeting of the AWA and 2 nd combined Annual Meeting of AWA and SafW, lecture and multiple chairs, 19.-20.6.2009, Zurich, Switzerland 25
Page 1 and 2: ______________________________ Addr
Page 3 and 4: � Additional Certificates 3/2010
Page 5 and 6: � Advisory Boards/Expert Groups 3
Page 7 and 8: 3/2010 Diseases (7/99); Contract N
Page 9 and 10: • The anti-microbial effect of th
Page 11 and 12: 3/2010 • CRYSTAL: Continuous vers
Page 13 and 14: � Developments/Patents • SKINWO
Page 15 and 16: 3/2010 • Genetische Aspekte des M
Page 17 and 18: • Sonne ohne Reue (Sun without re
Page 19 and 20: • Nanocristalline silver dressing
Page 21 and 22: • Entwicklung neuer Hautschutzma
Page 23: 3/2010 • Das atopische Ekzem (ato
Page 27 and 28: 3/2010 • 5 Jahre Etanercept: Rüc
Page 29 and 30: • R. STROHAL, G. KROEMER, H. WOLF
Page 31 and 32: 3/2010 • J. DISSEMOND, T. EBERLEI
Page 33 and 34: 3/2010 • J. GRAY AND ROBERT STROH
Page 35 and 36: � Community Relations and Media W
Page 37 and 38: 3/2010 - General dermatology, ask y
Page 39: - Sun without remorse awareness day

CURRICULUM VITAE Robert Strohal, MD - EWMA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?